Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine
2 years, 11 months ago

Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine

NPR  

Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine Enlarge this image toggle caption Jonas Roosens/Belga Mag/AFP via Getty Images Jonas Roosens/Belga Mag/AFP via Getty Images Pfizer and BioNTech have begun a clinical trial to evaluate a new, omicron-specific vaccine for COVID-19, the pharmaceutical companies announced Tuesday. "While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognize the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future," Kathrin U. Jansen, Pfizer's senior vice president and head of vaccine research and development, said in a statement. One group includes people who have already received two doses of the current Pfizer-BioNTech vaccine and will also receive the omicron vaccine. The Food and Drug Administration has authorized the current Pfizer-BioNTech COVID-19 vaccine for emergency use in people ages 5 and older.

Vaccine Omicron Pfizer  pfizer  protection  vaccine  current  roosensbelga  severe  omicronspecific  research  testing  omicron  includes  begin  covid19  biontech  receive

History of this topic

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Next round of COVID-19 shots in fall will target latest omicron strain
1 year, 6 months ago

Next round of COVID-19 shots in fall will target latest omicron strain

Associated Press  

NEW YORK — The next round of COVID-19 vaccines will target one of the latest versions of the coronavirus, the Food and Drug Administration said Friday. The agency told vaccine makers to provide protection against just one omicron strain, known as XBB.1.5. The three U.S. companies that make COVID-19 shots said this week they had geared up to make the …

An FDA panel meets about which COVID strains the U.S. will target with vaccines
1 year, 6 months ago

An FDA panel meets about which COVID strains the U.S. will target with vaccines

NPR  

An FDA panel meets about which COVID strains the U.S. will target with vaccines An advisory committee to the Food and Drug Administration meets to discuss the COVID strains that vaccines in the U.S. will target this fall. ARI SHAPIRO, HOST: Updated COVID vaccines are coming this fall, and they'll likely target a variant that's circulating now. HUANG: Yeah, you …

Protein-based booster shots help fight Omicron
1 year, 10 months ago

Protein-based booster shots help fight Omicron

China Daily  

A woman receives a booster dose in Chaoyang district of Beijing on July 13, 2022. China has recently rolled out two protein-based COVID-19 vaccines to serve as booster shots against Omicron subvariants, bringing new weapons to China's fight against mutated strains of the virus. The two vaccines are also recommended as a booster for those inoculated with three inactivated vaccines, …

Australian adults will be able to get fifth dose of COVID-19 vaccine later this month
1 year, 10 months ago

Australian adults will be able to get fifth dose of COVID-19 vaccine later this month

ABC  

Australian adults will be able to get a fifth dose of the COVID-19 vaccine within a fortnight, after the federal government accepted advice from its expert vaccine advisory body. Key points: From February 20, people 18 and over who have not had a COVID-19 vaccine or positive case in the last six months are eligible for another shot Uptake of …

First real-world data show Omicron booster kept seniors out of hospitals
1 year, 11 months ago

First real-world data show Omicron booster kept seniors out of hospitals

LA Times  

Vials of Pfizer and BioNTech’s Omicron-targeting COVID-19 vaccine are seen on a production line at a manufacturing facility in Kalamazoo, Mich. In the first real-world test of vaccine boosters specially designed to protect against the Omicron variant, Israeli researchers have found that people 65 and older who got an updated jab were 81% less likely to be hospitalized with COVID-19 …

Omicron boosters for the youngest children are here. Will they make a difference?
1 year, 11 months ago

Omicron boosters for the youngest children are here. Will they make a difference?

LA Times  

Updated COVID-19 booster shots are now available for the youngest children in California, a welcome development for officials hoping to augment vaccine coverage and head off a viral resurgence this winter. “We’re always concerned with lower vaccination rates among children,” said Los Angeles County Public Health Director Barbara Ferrer, “in particular because, as we’ve seen, some children will still get …

Pfizer says bivalent booster increases antibodies for Omicron variants
2 years, 2 months ago

Pfizer says bivalent booster increases antibodies for Omicron variants

LA Times  

Pfizer Inc. and its German vaccine partner BioNTech said their new COVID-19 booster designed to target the dominant Omicron subvariant produced more antibodies against the intended strains than did the original version of the shot. Pfizer and BioNTech plan to release additional data on the COVID-19 shots in the coming weeks to measure immune responses one month after administration of …

Husband and wife team behind Pfizer-BioNTech COVID shot insist pandemic ISN'T over
2 years, 2 months ago

Husband and wife team behind Pfizer-BioNTech COVID shot insist pandemic ISN'T over

Daily Mail  

The husband-and-wife duo behind BioNTech, the German firm that joined Pfizer to manufacture the COVID-19 vaccine, have unveiled plans for yet another new virus shot while warning that COVID isn't even close to being over. Dr. Ugur Sahin and Dr. Ozlem Tureci founded BioNTech in 2008 and count the Bill and Melinda Gates Foundation as one of their major investors …

How to get Omicron boosters at CVS, Walgreens, Rite Aid and other California locations
2 years, 3 months ago

How to get Omicron boosters at CVS, Walgreens, Rite Aid and other California locations

LA Times  

The new boosters protect against not only the Omicron subvariants BA.4 and BA.5, which have dominated the U.S. this summer, but also the original coronavirus strain. “The upgraded shots will help protect you in the upcoming weeks and months,” Orange County health officer Dr. Regina Chinsio-Kwong said in a briefing Tuesday. But that means protecting yourself against the variants that …

UK approves second 'bivalent' booster for Omicron, original COVID strain
2 years, 3 months ago

UK approves second 'bivalent' booster for Omicron, original COVID strain

India Today  

The UK health authorities on Saturday approved a second “bivalent” vaccine to be used as a booster vaccine to target both the Omicron and the original strain of COVID-19. In each dose of the booster vaccine called “Comirnaty bivalent Original/Omicron”, half of the vaccine targets the original virus strain and the other half targets Omicron. “The clinical trial of the …

EXPLAINER: Should you get a new COVID booster? If so, when?
2 years, 3 months ago

EXPLAINER: Should you get a new COVID booster? If so, when?

Associated Press  

John Wherry will wait until later in the fall to consider getting an updated COVID-19 booster. It’s the kind of calculation many Americans will face as booster shots that target currently circulating omicron strains become available to a population with widely varying risks and levels of immunity. Some advise at least three months, another said someone who’s not at high …

Omicron-specific boosters are here: How effective will these vaccines be in the fight against COVID-19?
2 years, 3 months ago

Omicron-specific boosters are here: How effective will these vaccines be in the fight against COVID-19?

Firstpost  

The new booster shots — one by Moderna and another from Pfizer-BioNTech – are specifically tailored to combat the two most recent and contagious Omicron subvariants, BA4 and BA5 On 31 August 2022, the Food and Drug Administration authorised the use of updated COVID-19 booster shots that are specifically tailored to combat the two most recent and contagious Omicron subvariants, …

US CDC endorses updated Covid boosters, shots to begin soon
2 years, 3 months ago

US CDC endorses updated Covid boosters, shots to begin soon

India Today  

The US Centers for Disease Control and Prevention on Thursday endorsed updated Covid-19 boosters, opening the way for a fall vaccination campaign that could blunt a winter surge if enough Americans roll up their sleeves. The CDC’s advisers struggled with who should get the new boosters and when because only a similarly tweaked vaccine, not the exact recipe, has been …

CDC Recommends Updated COVID-19 Vaccine Boosters Targeting Omicron Strains
2 years, 3 months ago

CDC Recommends Updated COVID-19 Vaccine Boosters Targeting Omicron Strains

Huff Post  

LOADING ERROR LOADING New COVID-19 boosters that target today’s most common omicron strains are set to begin soon after the Centers for Disease Control and Prevention endorsed the updated shots Thursday. The decision by CDC Director Rochelle Walensky came shortly after the agency’s advisers said if enough people roll up their sleeves, the shots could blunt a winter surge. The …

CDC endorses booster shots that target Omicron for Americans 12 and up
2 years, 3 months ago

CDC endorses booster shots that target Omicron for Americans 12 and up

LA Times  

The United States will replace most of its COVID-19 booster shots with updated versions that target the dominant Omicron strains and streamline its ongoing vaccination campaign, the Centers for Disease Control and Prevention announced Thursday. Going forward, Americans will be considered “up to date” with their COVID-19 vaccinations after receiving the bivalent booster, regardless of the total number of shots …

EMA approves updated Pfizer, Moderna Covid vaccines to fight Omicron variant
2 years, 3 months ago

EMA approves updated Pfizer, Moderna Covid vaccines to fight Omicron variant

NL Times  

The European Medicines Agency gave a positive recommendation to authorize the modified versions of the Covid-19 vaccines from Pfizer/BioNTech and Moderna, which should provide better protect against the Omicron variant of the virus, the European Union's medicines watchdog said on Thursday. The committee judged that the modified vaccines provide a strong immune response against both the original variant, and the …

U.S. authorizes updated COVID-19 boosters targeting newest variants
2 years, 3 months ago

U.S. authorizes updated COVID-19 boosters targeting newest variants

LA Times  

The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common Omicron strains. “Give a clear, forward-looking set of expectations.” Here’s the rub: The original vaccines still offer strong protection against severe disease and death from COVID-19 for most generally healthy people, especially if they got that important first booster dose. First, FDA …

US approves updated COVID boosters targeting Omicron variants
2 years, 3 months ago

US approves updated COVID boosters targeting Omicron variants

Al Jazeera  

Drugmaker Pfizer said it has doses ready to ship and can deliver up to 15 million shots by the end of next week. The United States has authorised booster doses of the COVID-19 vaccines that target the most common Omicron strain, and shots could be available within days. “You’ll see me at the front of the line,” FDA vaccine chief …

Omicron COVID-19 booster shots are coming: Will they be a game-changer?
2 years, 3 months ago

Omicron COVID-19 booster shots are coming: Will they be a game-changer?

LA Times  

Nurse Jerrold Sarte gives Dr. Bahareh Gordon her second booster shot at a vaccination clinic at Balboa Sports Complex in Encino on May 21. The next generation of COVID-19 booster shots — tailored specifically to combat the super-infectious family of Omicron subvariants — could roll out early next month. The Omicron booster, Jha added, represents a potentially substantial upgrade in …

Pfizer COVID vaccine 73% effective in children aged between 6 months and 4 years
2 years, 4 months ago

Pfizer COVID vaccine 73% effective in children aged between 6 months and 4 years

Live Mint  

Pfizer said that its COVID vaccine is 73.2% effective in the age group of 6 months to 4 years. The updated data released on Tuesday showed 13 children had COVID-19, at least seven days after receiving a third dose of the Pfizer-BioNTech COVID-19 vaccine, compared with 21 cases in those who received a placebo. The companies also said they were …

Pfizer’s COVID shots appear 73% effective in children under 5
2 years, 4 months ago

Pfizer’s COVID shots appear 73% effective in children under 5

LA Times  

New data from Pfizer and BioNTech show their COVID-19 vaccine was 73% effective at protecting children younger than 5 as Omicron spread in the spring. Pfizer’s COVID-19 vaccine was 73% effective in protecting children younger than 5 as Omicron spread in the spring, the company announced Tuesday. Health authorities authorized the smaller vaccine doses made by Pfizer and its partner …

Pfizer seeks OK of COVID booster that targets Omicron
2 years, 4 months ago

Pfizer seeks OK of COVID booster that targets Omicron

LA Times  

A health worker administers a dose of Pfizer’s Comirnaty COVID-19 vaccine in Reading, Pa. Pfizer has asked U.S. regulators to authorize its combination COVID-19 shot that adds protection against Omicron subvariants. Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against Omicron subvariants, a key step toward opening a fall booster campaign. The U.S. has …

Omicron-specific COVID-19 booster may be available in a few weeks, officials say
2 years, 4 months ago

Omicron-specific COVID-19 booster may be available in a few weeks, officials say

LA Times  

Michael Stremfel, owner of Flintridge Pharmacy in La Canada, prepares a COVID-19 booster in November 2021. The Omicron-specific COVID-19 booster may be available in a few weeks, assuming federal agencies sign off on the new shot, a top White House COVID-19 official said this week. The booster has been widely expected for months, especially since the latest dominant Omicron subvariant, …

Omicron-targeted COVID vaccine gets approval: All you need to know
2 years, 4 months ago

Omicron-targeted COVID vaccine gets approval: All you need to know

Live Mint  

Late last year, the Omicron COVID variant was first spotted in South Africa and within months, it became the dominant coronavirus strain the world over. Owing to this, the experts have been working on an Omicron-specific vaccine that became a reality recently with Moderna Inc. receiving approval from the UK government for a Covid-19 booster shot that targets omicron. The …

Pfizer CEO tests positive for COVID-19, has mild symptoms
2 years, 4 months ago

Pfizer CEO tests positive for COVID-19, has mild symptoms

LA Times  

Albert Bourla, chief executive officer of Pfizer, speaks at the World Economic Forum in Davos, Switzerland, in May. Bourla said Monday that he has a very mild case of COVID-19 and has started taking Pfizer’s Paxlovid pill. The top executive at Pfizer, a leading producer of COVID-19 vaccines and medicines, has tested positive for the virus and says he is …

White House urges caution on COVID variants, pushes boosters
2 years, 5 months ago

White House urges caution on COVID variants, pushes boosters

Associated Press  

WASHINGTON — The Biden administration is calling on people to exercise renewed caution about COVID-19, emphasizing the importance of getting booster shots for those who are eligible and wearing masks indoors as two new highly transmissible variants are spreading rapidly across the country. “If you’re over 50 and you haven’t gotten the shot this year, you should go get a …

Tweaked COVID boosters in US must target newer omicron types
2 years, 5 months ago

Tweaked COVID boosters in US must target newer omicron types

Associated Press  

U.S. regulators told COVID-19 vaccine makers Thursday that any booster shots tweaked for the fall will have to add protection against the newest omicron relatives. And the current Pfizer and Moderna vaccines still offer strong protection against COVID-19’s worst outcomes as long as people have gotten already recommended boosters. The FDA’s decision comes after its scientific advisers earlier this week …

FDA advisers recommend updating COVID booster shots for fall
2 years, 5 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA advisors recommend updating COVID booster shot formula for fall
2 years, 5 months ago

FDA advisors recommend updating COVID booster shot formula for fall

LA Times  

Advisors to the Food and Drug Administration are recommending that some U.S. adults get a modified COVID-19 booster shot this fall that better matches the recent variants. Some U.S. adults are a step closer to getting updated COVID-19 boosters this fall, as government advisors voted Tuesday that it’s time to tweak the shots to better match the most recent virus …

Pfizer says tweaked COVID-19 shots boost Omicron protection
2 years, 5 months ago

Pfizer says tweaked COVID-19 shots boost Omicron protection

LA Times  

Pfizer and its partner BioNTech studied two ways of updating their vaccine. Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the Omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall. Pfizer and its partner BioNTech studied two ways of updating their shots — targeting just …

FDA authorizes Covid-19 vaccines for younger children
2 years, 6 months ago

FDA authorizes Covid-19 vaccines for younger children

CNN  

CNN — The Moderna and Pfizer/BioNTech Covid-19 vaccines are now authorized for emergency use in young children. “I’m really pleased that we’ve reached this kind of milestone,” said committee member Dr. Ofer Levy, of the Precision Vaccines Program at Boston Children’s Hospital, who also likened the moment to when Covid-19 vaccines previously were authorized for other age groups. “Having vaccine …

Moderna says updated COVID shot boosts omicron protection
2 years, 6 months ago

Moderna says updated COVID shot boosts omicron protection

Associated Press  

Moderna’s experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced Wednesday. Moderna’s preliminary study results show people given the combination shot experienced a higher boost in omicron-fighting antibodies than if they just got a fourth dose of the original vaccine. They’re still providing strong protection against severe disease, hospitalization …

CDC urges Pfizer booster for children ages 5 to 11
2 years, 7 months ago

CDC urges Pfizer booster for children ages 5 to 11

LA Times  

A nurse holds a vial of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, right, alongside a vial of the vaccine for adults. Kids ages 5 to 11 should get a booster dose of Pfizer’s COVID-19 vaccine, the Centers for Disease Control and Prevention said Thursday after an endorsement from an advisory panel. “Vaccination with a primary series …

Pfizer and BioNTech say Covid booster dose increases protection against Omicron in kids aged 5-11
2 years, 8 months ago

Pfizer and BioNTech say Covid booster dose increases protection against Omicron in kids aged 5-11

India Today  

A booster dose of Pfizer Inc and BioNTech's Covid vaccine produced significant protection against the Omicron variant in children aged between 5 and 11 years, the firms said on Thursday. The phase 2/3 clinical trial was testing the safety and immunogenicity of a 10 microgram booster dose in 140 healthy children aged 5 through 11 years. Pfizer and BioNTech said …

Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines
2 years, 8 months ago

Another booster? A vaccine for omicron? Here's what could be next for COVID vaccines

NPR  

A vaccine for omicron? Here's what could be next for COVID vaccines Enlarge this image toggle caption Dinendra Haria/SOPA Images/LightRocket via Getty Images Dinendra Haria/SOPA Images/LightRocket via Getty Images Most vaccinated people will probably require yet another COVID-19 vaccine booster shot in the fall, a top Food and Drug Administration official said Monday. Sponsor Message "We could basically wait until …

Booster dose of COVID-19 vaccine needed to fight against Omicron, says study
2 years, 8 months ago

Booster dose of COVID-19 vaccine needed to fight against Omicron, says study

Firstpost  

New Delhi: Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both — Covishield as the first dose and Covaxin as the second dose with regard to Omicron variant, a study done by the National Institute of Virology in Pune has indicated. The heterologous vaccination regimen …

Covid-19: US FDA approves another Pfizer, Moderna booster dose for age 50 and up
2 years, 8 months ago

Covid-19: US FDA approves another Pfizer, Moderna booster dose for age 50 and up

India Today  

US regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration's decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at least four months after their previous booster. Pfizer had asked the …

Pfizer seeks authorisation for fourth COVID-19 vaccine jab for those above 65 years
2 years, 9 months ago

Pfizer seeks authorisation for fourth COVID-19 vaccine jab for those above 65 years

Firstpost  

The new application seeks to add a fourth shot only for the over-65 population that has been hit hardest by the pandemic. Pfizer and its partner BioNTech asked US regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit. With COVID-19 cases finally plummeting after the intense …

Pfizer asks U.S. to allow fourth COVID vaccine dose for seniors
2 years, 9 months ago

Pfizer asks U.S. to allow fourth COVID vaccine dose for seniors

LA Times  

Pfizer could add a fourth vaccine dose in an effort to provide maximum protection to the over-65 population that has been hit hardest by the pandemic. Pfizer and its partner BioNTech asked U.S. regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggest older adults would benefit. With COVID-19 cases finally …

Pfizer shots protect kids from severe COVID even in omicron
2 years, 9 months ago

Pfizer shots protect kids from severe COVID even in omicron

Associated Press  

Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge that hit youngsters especially hard, U.S. health officials reported Tuesday. He said youngsters admitted to his hospital with severe COVID-19 are the unvaccinated “and it’s hard to watch.” The CDC reported Tuesday that between April and early January there were nine …

Pfizer shots protect kids from severe COVID-19, even in Omicron surge
2 years, 9 months ago

Pfizer shots protect kids from severe COVID-19, even in Omicron surge

LA Times  

A nurse holds a vial of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, right, alongside a vial for adults. Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the Omicron surge, which hit youngsters especially hard, U.S. health officials reported Tuesday. But the CDC said data from multiple other states …

The Pfizer COVID-19 vaccine is only 12% effective against infection in children aged five to 11
2 years, 9 months ago

The Pfizer COVID-19 vaccine is only 12% effective against infection in children aged five to 11

Daily Mail  

The Pfizer-BioNTech COVID-19 vaccine has done little to protect five- to 11- year-olds from infection from the Omicron variant, data revealed by New York state officials on Monday shows. New York State officials revealed Monday that children aged five to 11 years old that receive the COVID-19 vaccine only have their risk of infection dropped by 12%. New York researchers …

Covid vaccine efficacy limited against Omicron, says study
2 years, 10 months ago

Covid vaccine efficacy limited against Omicron, says study

India Today  

People who are double-vaccinated and those who have recovered from infection by previous strains of the SARS-CoV-2 virus have virtually no antibody protection against the Omicron variant, according to a study. Read: Very small blood clot risk after first AstraZeneca Covid shot, say UK studies They adapted for Omicron a test developed for the previous variants, which investigates whether the …

A different COVID-19 vaccine debate: Do we need new shots?
2 years, 10 months ago

A different COVID-19 vaccine debate: Do we need new shots?

LA Times  

A technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company’s facility in Puurs, Belgium. to believe that any kind of vaccination is going to protect people from infection, from mild symptomatic disease, forever.” If the goal is preventing serious illness, “we may not need to be doing as much fine-tuning of the vaccines every time a new …

Pfizer and BioNTech seeking emergency use authorization from FDA for Covid-19 vaccine for children younger than 5
2 years, 10 months ago

Pfizer and BioNTech seeking emergency use authorization from FDA for Covid-19 vaccine for children younger than 5

CNN  

CNN — Pfizer and BioNTech are requesting emergency use authorization for their two-dose Covid-19 vaccine for children age 6 months up to 5 years, the companies said Tuesday. “Ultimately, we believe that three doses of the vaccine will be needed for children 6 months through 4 years of age to achieve high levels of protection against current and potential future …

U.S. urges Pfizer to apply for vaccine for children under 5
2 years, 10 months ago

U.S. urges Pfizer to apply for vaccine for children under 5

LA Times  

U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 5 and under. U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old while awaiting data on a three-dose course, aiming to …

Moderna starts trial of Omicron-specific COVID vaccine booster
2 years, 10 months ago

Moderna starts trial of Omicron-specific COVID vaccine booster

Al Jazeera  

Moderna says it will study its Omicron-specific vaccine booster in adults aged 18 years and older. Moderna Inc has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically designed to target the Omicron coronavirus variant, a day after rival Pfizer Inc launched a similar trial. The company said on Wednesday that while a third shot of …

Pfizer begins testing omicron-matched COVID shots in adults
2 years, 10 months ago

Pfizer begins testing omicron-matched COVID shots in adults

Deccan Chronicle  

Pfizer is enrolling healthy adults to test a reformulated COVID-19 vaccine that matches the hugely contagious omicron variant, to see how it compares with the original shots. Another wrinkle in deciding whether vaccines need an update: A new U.S. report Tuesday echoes data from Britain and South Africa that omicron infections cause less severe illness — at least in part …

Discover Related